UniProt ID | BORG4_HUMAN | |
---|---|---|
UniProt AC | Q9H3Q1 | |
Protein Name | Cdc42 effector protein 4 | |
Gene Name | CDC42EP4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 356 | |
Subcellular Localization |
Endomembrane system Peripheral membrane protein. Cytoplasm, cytoskeleton. |
|
Protein Description | Probably involved in the organization of the actin cytoskeleton. May act downstream of CDC42 to induce actin filament assembly leading to cell shape changes. Induces pseudopodia formation, when overexpressed in fibroblasts.. | |
Protein Sequence | MPILKQLVSSSVHSKRRSRADLTAEMISAPLGDFRHTMHVGRAGDAFGDTSFLNSKAGEPDGESLDEQPSSSSSKRSLLSRKFRGSKRSQSVTRGEREQRDMLGSLRDSALFVKNAMSLPQLNEKEAAEKGTSKLPKSLSSSPVKKANDGEGGDEEAGTEEAVPRRNGAAGPHSPDPLLDEQAFGDLTDLPVVPKATYGLKHAESIMSFHIDLGPSMLGDVLSIMDKEEWDPEEGEGGYHGDEGAAGTITQAPPYAVAAPPLARQEGKAGPDLPSLPSHALEDEGWAAAAPSPGSARSMGSHTTRDSSSLSSCTSGILEERSPAFRGPDRARAAVSRQPDKEFSFMDEEEEDEIRV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Methylation | ---MPILKQLVSSSV ---CCHHHHHHHCCH | 42.16 | 24129315 | |
5 | Ubiquitination | ---MPILKQLVSSSV ---CCHHHHHHHCCH | 42.16 | - | |
9 | Phosphorylation | PILKQLVSSSVHSKR CHHHHHHHCCHHHCC | 26.03 | 30266825 | |
10 | Phosphorylation | ILKQLVSSSVHSKRR HHHHHHHCCHHHCCC | 28.97 | 30266825 | |
11 | Phosphorylation | LKQLVSSSVHSKRRS HHHHHHCCHHHCCCC | 19.15 | 23401153 | |
14 | Phosphorylation | LVSSSVHSKRRSRAD HHHCCHHHCCCCHHH | 26.21 | 30266825 | |
15 | Ubiquitination | VSSSVHSKRRSRADL HHCCHHHCCCCHHHH | 36.63 | - | |
18 | Phosphorylation | SVHSKRRSRADLTAE CHHHCCCCHHHHHHH | 35.53 | 30266825 | |
23 | Phosphorylation | RRSRADLTAEMISAP CCCHHHHHHHHHHCC | 22.56 | 30266825 | |
28 | Phosphorylation | DLTAEMISAPLGDFR HHHHHHHHCCCCCCC | 23.64 | 23927012 | |
42 | Methylation | RHTMHVGRAGDAFGD CCCEECCCCCCCCCC | 34.02 | - | |
50 | Phosphorylation | AGDAFGDTSFLNSKA CCCCCCCCHHHCCCC | 23.04 | 29396449 | |
51 | Phosphorylation | GDAFGDTSFLNSKAG CCCCCCCHHHCCCCC | 32.26 | 21815630 | |
56 | Ubiquitination | DTSFLNSKAGEPDGE CCHHHCCCCCCCCCC | 60.38 | - | |
64 | Phosphorylation | AGEPDGESLDEQPSS CCCCCCCCCCCCCCC | 46.80 | 19664994 | |
68 (in isoform 2) | Phosphorylation | - | 42.73 | 29743597 | |
70 | Phosphorylation | ESLDEQPSSSSSKRS CCCCCCCCCCHHHHH | 42.41 | 22167270 | |
71 | Phosphorylation | SLDEQPSSSSSKRSL CCCCCCCCCHHHHHH | 40.71 | 22167270 | |
72 | Phosphorylation | LDEQPSSSSSKRSLL CCCCCCCCHHHHHHH | 42.86 | 22167270 | |
73 | Phosphorylation | DEQPSSSSSKRSLLS CCCCCCCHHHHHHHH | 41.65 | 22167270 | |
74 | Phosphorylation | EQPSSSSSKRSLLSR CCCCCCHHHHHHHHH | 33.75 | 23927012 | |
75 | Ubiquitination | QPSSSSSKRSLLSRK CCCCCHHHHHHHHHH | 48.21 | 21906983 | |
76 | Ubiquitination | PSSSSSKRSLLSRKF CCCCHHHHHHHHHHH | 34.19 | - | |
77 | Phosphorylation | SSSSSKRSLLSRKFR CCCHHHHHHHHHHHC | 37.08 | 29496963 | |
80 | Phosphorylation | SSKRSLLSRKFRGSK HHHHHHHHHHHCCCH | 38.42 | 25137130 | |
86 | O-linked_Glycosylation | LSRKFRGSKRSQSVT HHHHHCCCHHHCCCC | 22.19 | 30379171 | |
89 | Phosphorylation | KFRGSKRSQSVTRGE HHCCCHHHCCCCCHH | 30.46 | 22617229 | |
91 | Phosphorylation | RGSKRSQSVTRGERE CCCHHHCCCCCHHHH | 27.05 | 26329039 | |
93 | Phosphorylation | SKRSQSVTRGEREQR CHHHCCCCCHHHHHH | 37.90 | 26434776 | |
105 | Phosphorylation | EQRDMLGSLRDSALF HHHHHHHHHHHHHHH | 19.10 | 25463755 | |
109 | Phosphorylation | MLGSLRDSALFVKNA HHHHHHHHHHHHHCC | 22.04 | 29255136 | |
114 | Ubiquitination | RDSALFVKNAMSLPQ HHHHHHHHCCCCCCC | 31.49 | 21906983 | |
118 | Phosphorylation | LFVKNAMSLPQLNEK HHHHCCCCCCCCCHH | 34.19 | 19664994 | |
125 | Ubiquitination | SLPQLNEKEAAEKGT CCCCCCHHHHHHHCC | 52.13 | 21906983 | |
138 | Phosphorylation | GTSKLPKSLSSSPVK CCCCCCHHHCCCCCE | 31.38 | 23927012 | |
140 | Phosphorylation | SKLPKSLSSSPVKKA CCCCHHHCCCCCEEC | 35.54 | 22167270 | |
141 | Phosphorylation | KLPKSLSSSPVKKAN CCCHHHCCCCCEECC | 43.91 | 30266825 | |
142 | Phosphorylation | LPKSLSSSPVKKAND CCHHHCCCCCEECCC | 30.27 | 22167270 | |
146 | Ubiquitination | LSSSPVKKANDGEGG HCCCCCEECCCCCCC | 53.29 | 21906983 | |
159 | Phosphorylation | GGDEEAGTEEAVPRR CCCCCCCCCCCCCCC | 37.39 | 23312004 | |
174 | Phosphorylation | NGAAGPHSPDPLLDE CCCCCCCCCCCCCCC | 33.85 | 25159151 | |
188 | Phosphorylation | EQAFGDLTDLPVVPK CHHCCCCCCCCCCCC | 39.98 | 23927012 | |
255 | Phosphorylation | TITQAPPYAVAAPPL CCCCCCCCEEECCCH | 16.79 | 22817900 | |
275 | Phosphorylation | KAGPDLPSLPSHALE CCCCCCCCCCHHHHC | 61.28 | 23927012 | |
278 | Phosphorylation | PDLPSLPSHALEDEG CCCCCCCHHHHCCCC | 27.04 | 23927012 | |
292 | Phosphorylation | GWAAAAPSPGSARSM CCCCCCCCCCCCCCC | 36.85 | 22167270 | |
295 | Phosphorylation | AAAPSPGSARSMGSH CCCCCCCCCCCCCCC | 24.72 | 22167270 | |
298 | Phosphorylation | PSPGSARSMGSHTTR CCCCCCCCCCCCCCC | 27.49 | 20363803 | |
301 | Phosphorylation | GSARSMGSHTTRDSS CCCCCCCCCCCCCCC | 14.71 | 20363803 | |
303 | Phosphorylation | ARSMGSHTTRDSSSL CCCCCCCCCCCCCHH | 25.81 | 28857561 | |
304 | Phosphorylation | RSMGSHTTRDSSSLS CCCCCCCCCCCCHHC | 27.36 | 23403867 | |
307 | Phosphorylation | GSHTTRDSSSLSSCT CCCCCCCCCHHCCCC | 20.66 | 29507054 | |
308 | Phosphorylation | SHTTRDSSSLSSCTS CCCCCCCCHHCCCCC | 39.32 | 30266825 | |
309 | Phosphorylation | HTTRDSSSLSSCTSG CCCCCCCHHCCCCCH | 35.90 | 26657352 | |
311 | Phosphorylation | TRDSSSLSSCTSGIL CCCCCHHCCCCCHHH | 25.89 | 30266825 | |
312 | Phosphorylation | RDSSSLSSCTSGILE CCCCHHCCCCCHHHH | 27.06 | 29978859 | |
314 | Phosphorylation | SSSLSSCTSGILEER CCHHCCCCCHHHHCC | 31.75 | 29978859 | |
315 | Phosphorylation | SSLSSCTSGILEERS CHHCCCCCHHHHCCC | 28.32 | 29978859 | |
322 | Phosphorylation | SGILEERSPAFRGPD CHHHHCCCHHHCCCH | 24.70 | 30266825 | |
344 | Phosphorylation | RQPDKEFSFMDEEEE CCCCCCCCCCCHHHH | 22.28 | 22617229 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BORG4_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BORG4_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
A4_HUMAN | APP | physical | 21832049 | |
FAM9B_HUMAN | FAM9B | physical | 25416956 | |
SEPT4_HUMAN | SEPT4 | physical | 26186194 | |
SEPT2_HUMAN | SEPT2 | physical | 26186194 | |
SEPT7_HUMAN | SEPT7 | physical | 26186194 | |
SEPT5_HUMAN | SEPT5 | physical | 26186194 | |
SEPT6_HUMAN | SEPT6 | physical | 26186194 | |
SEPT8_HUMAN | SEPT8 | physical | 26186194 | |
SEP11_HUMAN | SEPT11 | physical | 26186194 | |
SEPT9_HUMAN | SEPT9 | physical | 26186194 | |
SEPT3_HUMAN | SEPT3 | physical | 26186194 | |
KLH15_HUMAN | KLHL15 | physical | 26186194 | |
SEP10_HUMAN | SEPT10 | physical | 26186194 | |
YBEY_HUMAN | YBEY | physical | 26186194 | |
FHL2_HUMAN | FHL2 | physical | 26186194 | |
SEP10_HUMAN | SEPT10 | physical | 28514442 | |
SEPT3_HUMAN | SEPT3 | physical | 28514442 | |
SEPT8_HUMAN | SEPT8 | physical | 28514442 | |
SEPT5_HUMAN | SEPT5 | physical | 28514442 | |
SEPT2_HUMAN | SEPT2 | physical | 28514442 | |
SEPT6_HUMAN | SEPT6 | physical | 28514442 | |
SEPT7_HUMAN | SEPT7 | physical | 28514442 | |
SEP11_HUMAN | SEPT11 | physical | 28514442 | |
SEPT9_HUMAN | SEPT9 | physical | 28514442 | |
SEPT4_HUMAN | SEPT4 | physical | 28514442 | |
SEP14_HUMAN | SEPT14 | physical | 28514442 | |
FHL2_HUMAN | FHL2 | physical | 28514442 | |
KLH15_HUMAN | KLHL15 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-64, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-64; SER-138; SER-142;SER-174; SER-292 AND SER-295, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-292 AND SER-295, ANDMASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-292 AND SER-295, ANDMASS SPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-174; SER-292 ANDSER-295, AND MASS SPECTROMETRY. |